Cell Reports Medicine is a premium open-access journal from Cell Press publishing cutting-edge research in translational and clinical biomedical sciences that inform and influence human health and medicine.

The content published in Cell Reports Medicine reaches a broad range of scientists and clinicians across the spectrum of medical disciplines, ensuring that your work will be both visible and accessible. The journal publishes original research that ranges from exciting concepts in human biology, health, and disease to all phases of clinical work. We encourage submissions featuring innovative ideas that open up new directions in clinical research and practice, as well as studies that provide critical information that enriches our understanding of current standards of care in diagnosis, treatment, and prognosis. This includes, but is not limited to, translational studies, clinical trials in all areas of medicine including long-term trial follow-ups as well as work in genomics, biomarker discovery, and developments in technology that contribute to diagnostics, treatment, and healthcare. Studies based on vertebrate model organisms also fall within the scope of the journal, provided that the results are directly relevant to human health and disease.

Like our sister journal Cell Reports, we will consider impactful, single-point papers called reports, in addition to longer articles. Large datasets, techniques, and tools for the community can also be considered under the article format. We will also publish reviews covering recent literature in emerging and active fields.

The professional in-house scientific editors at Cell Reports Medicine work closely with authors, reviewers, and the journal's editorial board to ensure exemplary editorial process, fair and robust peer review, and rapid dissemination and communication of your research.

Cell Reports Medicine 是 Cell Press 出版的优质开放获取期刊，发表转化和临床生物医学领域的前沿研究，为人类健康和医学提供信息和影响。

Cell Reports Medicine 上发表的内容覆盖了医学领域各个领域的科学家和临床医生，确保您的工作既可见又可访问。该期刊发表的原创研究范围从人类生物学、健康和疾病的激动人心的概念到临床工作的所有阶段。我们鼓励提交具有创新思想的论文，这些思想可以开辟临床研究和实践的新方向，以及提供关键信息的研究，这些研究可以丰富我们对诊断、治疗和预后当前护理标准的理解。这包括但不限于转化研究、医学所有领域的临床试验（包括长期试验随访）以及基因组学、生物标志物发现和有助于诊断、治疗和医疗保健的技术发展方面的工作。基于脊椎动物模型生物的研究也属于该期刊的范畴，前提是研究结果与人类健康和疾病直接相关。

与我们的姊妹期刊《Cell Reports》一样，除了较长的文章外，我们还会考虑有影响力的单点论文（称为报告）。社区的大型数据集、技术和工具也可以在文章格式下考虑。我们还将发表涵盖新兴和活跃领域的最新文献的评论。

《Cell Reports Medicine》的专业内部科学编辑与作者、审稿人和期刊编辑委员会密切合作，以确保出色的编辑过程、公平而严格的同行评审以及快速传播和交流您的研究。

该刊已被国际权威数据库SCIE收录，是国际顶级期刊。该刊致力于发表经过严格同行评审的高质量原创文章，反映Biochemistry, Genetics and Molecular Biology-Biochemistry, Genetics and Molecular Biology (all)领域的新进展、新技术、新成果，促进该领域科研交流和科研成果转化。该刊2023年影响因子为11.7，平均审稿速度为约Time to desk decision: 6.6 days; Publication time: 3.31 weeks 17 Weeks ，近四年来没有被列入预警名单。如果您需要投稿发表服务及指导，可以联系我们的客服老师，我们专业专注服务期刊投稿协助10年，为您提供期刊投稿个性化定制服务，并且我们确保严格保密您的个人信息及稿件内容。